bemrist breezhaler
novartis europharm limited - indacaterol, mometasone furoate - astma - léky na obstrukční onemocnění dýchacích cest, - bemrist breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
atectura breezhaler
novartis europharm limited - indacaterol acetate, mometasone furoate - astma - léky na obstrukční onemocnění dýchacích cest, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
mometason furoát cipla 50mcg/dáv nosní sprej, suspenze
cipla europe nv, antverpy array - 14957 monohydrÁt mometason-furoÁtu - nosní sprej, suspenze - 50mcg/dÁv - mometason
asmanex 200mcg prášek k inhalaci
n.v. organon, oss array - 9992 mometason-furoÁt - prášek k inhalaci - 200mcg - mometason
asmanex 400mcg prášek k inhalaci
n.v. organon, oss array - 9992 mometason-furoÁt - prášek k inhalaci - 400mcg - mometason
elocom 1mg/g krém
n.v. organon, oss array - 9992 mometason-furoÁt - krém - 1mg/g - mometason
elocom 1mg/g kožní roztok
n.v. organon, oss array - 9992 mometason-furoÁt - kožní roztok - 1mg/g - mometason
elocom 1mg/g mast
n.v. organon, oss array - 9992 mometason-furoÁt - mast - 1mg/g - mometason
ryaltris 25mcg/600mcg/dáv nosní sprej, suspenze
glenmark pharmaceuticals s.r.o., praha array - 14957 monohydrÁt mometason-furoÁtu; 16715 olopatadin-hydrochlorid - nosní sprej, suspenze - 25mcg/600mcg/dÁv - mometason, kombinace
mommox 0,05mg/dáv nosní sprej, suspenze
sandoz s.r.o., praha array - 14957 monohydrÁt mometason-furoÁtu - nosní sprej, suspenze - 0,05mg/dÁv - mometason